Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12868191rdf:typepubmed:Citationlld:pubmed
pubmed-article:12868191lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:12868191lifeskim:mentionsumls-concept:C0032143lld:lifeskim
pubmed-article:12868191lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:12868191lifeskim:mentionsumls-concept:C1704321lld:lifeskim
pubmed-article:12868191lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:12868191lifeskim:mentionsumls-concept:C1418824lld:lifeskim
pubmed-article:12868191pubmed:issue82lld:pubmed
pubmed-article:12868191pubmed:dateCreated2003-7-18lld:pubmed
pubmed-article:12868191pubmed:abstractTextPatients with idiopathic nephrotic syndrome (INS) are at increased risk of thromboembolic events at every stage of the disease. We assessed the function of the coagulation cascade and fibrinolysis in stable remission of INS, in children treated with cyclosporine A.lld:pubmed
pubmed-article:12868191pubmed:languagepollld:pubmed
pubmed-article:12868191pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12868191pubmed:citationSubsetIMlld:pubmed
pubmed-article:12868191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12868191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12868191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12868191pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12868191pubmed:statusMEDLINElld:pubmed
pubmed-article:12868191pubmed:monthAprlld:pubmed
pubmed-article:12868191pubmed:issn1426-9686lld:pubmed
pubmed-article:12868191pubmed:authorpubmed-author:NowickiMicha...lld:pubmed
pubmed-article:12868191pubmed:authorpubmed-author:TkaczykMarcin...lld:pubmed
pubmed-article:12868191pubmed:authorpubmed-author:FinkeDariaDlld:pubmed
pubmed-article:12868191pubmed:authorpubmed-author:OwczarekDanut...lld:pubmed
pubmed-article:12868191pubmed:issnTypePrintlld:pubmed
pubmed-article:12868191pubmed:volume14lld:pubmed
pubmed-article:12868191pubmed:ownerNLMlld:pubmed
pubmed-article:12868191pubmed:authorsCompleteYlld:pubmed
pubmed-article:12868191pubmed:pagination315-8lld:pubmed
pubmed-article:12868191pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:meshHeadingpubmed-meshheading:12868191...lld:pubmed
pubmed-article:12868191pubmed:year2003lld:pubmed
pubmed-article:12868191pubmed:articleTitle[Concentration of tissue plasminogen activator and its inhibitor 1 in cyclosporine A-treated children with idiopathic nephrotic syndrome].lld:pubmed
pubmed-article:12868191pubmed:affiliationmtkaczyk@uni.lodz.pllld:pubmed
pubmed-article:12868191pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12868191pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:12868191pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed